BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 19141059)

  • 1. Systemic treatment of anti-CD4CD25 T cell monoclonal antibody exacerbates sialoadenitis in submandibular glands during the early life in lupus-prone female NZB x NZWF mice.
    Hayashi T; Adachi C; Hasegawa K
    J Oral Pathol Med; 2009 Feb; 38(2):234-40. PubMed ID: 19141059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effective treatment of a mouse model of Sjögren's syndrome with eyedrop administration of anti-CD4 monoclonal antibody.
    Hayashi Y; Ishimaru N; Arakaki R; Tsukumo S; Fukui H; Kishihara K; Shiota H; Yasutomo K; Hayashi Y
    Arthritis Rheum; 2004 Sep; 50(9):2903-10. PubMed ID: 15457459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polyclonal B cell activation arises from different mechanisms in lupus-prone (NZB x NZW)F1 and MRL/MpJ-lpr/lpr mice.
    Merino R; Iwamoto M; Fossati L; Izui S
    J Immunol; 1993 Dec; 151(11):6509-16. PubMed ID: 7902378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Ganoderma lucidum spores on sialoadenitis of nonobese diabetic mice.
    Qi G; Hua H; Gao Y; Lin Q; Yu GY
    Chin Med J (Engl); 2009 Mar; 122(5):556-60. PubMed ID: 19323907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of CD4CD25 T cells in autoantibody production in murine lupus.
    Hsu WT; Suen JL; Chiang BL
    Clin Exp Immunol; 2006 Sep; 145(3):513-9. PubMed ID: 16907921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The histone deacetylase inhibitor trichostatin A upregulates regulatory T cells and modulates autoimmunity in NZB/W F1 mice.
    Reilly CM; Thomas M; Gogal R; Olgun S; Santo A; Sodhi R; Samy ET; Peng SL; Gilkeson GS; Mishra N
    J Autoimmun; 2008 Sep; 31(2):123-30. PubMed ID: 18650065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenic role of immune response to M3 muscarinic acetylcholine receptor in Sjögren's syndrome-like sialoadenitis.
    Iizuka M; Wakamatsu E; Tsuboi H; Nakamura Y; Hayashi T; Matsui M; Goto D; Ito S; Matsumoto I; Sumida T
    J Autoimmun; 2010 Dec; 35(4):383-9. PubMed ID: 20864316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Destruction of salivary and lacrimal glands by Th1-polarized reaction in a model of secondary Sjögren's syndrome in lupus-prone female NZB × NZWF(1) mice.
    Hayashi T; Shimoyama N; Mizuno T
    Inflammation; 2012 Apr; 35(2):638-46. PubMed ID: 21786007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paradoxic effect of anti-CD4 therapy on lacrimal gland disease in MRL/Mp-lpr/lpr mice.
    Jabs DA; Burns WH; Prendergast RA
    Invest Ophthalmol Vis Sci; 1996 Jan; 37(1):246-50. PubMed ID: 8550330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection against renal disease in (NZB x NZW)F(1) lupus-prone mice after somatic B cell gene vaccination with anti-DNA immunoglobulin consensus peptide.
    Ferrera F; Hahn BH; Rizzi M; Anderson M; Fitzgerald J; Millo E; Indiveri F; Shi FD; Filaci G; La Cava A
    Arthritis Rheum; 2007 Jun; 56(6):1945-53. PubMed ID: 17530718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new animal model for primary Sjögren's syndrome in NFS/sld mutant mice.
    Haneji N; Hamano H; Yanagi K; Hayashi Y
    J Immunol; 1994 Sep; 153(6):2769-77. PubMed ID: 8077681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of autoimmune arthritis with aging via bystander T cell activation in the mouse model of Sjögren's syndrome.
    Kobayashi M; Yasui N; Ishimaru N; Arakaki R; Hayashi Y
    Arthritis Rheum; 2004 Dec; 50(12):3974-84. PubMed ID: 15593201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of innate immunity accelerates sialoadenitis in a mouse model for Sjögren's syndrome-like disease.
    Nandula SR; Scindia YM; Dey P; Bagavant H; Deshmukh US
    Oral Dis; 2011 Nov; 17(8):801-7. PubMed ID: 21815968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sjögren's syndrome in the NOD mouse model is an interleukin-4 time-dependent, antibody isotype-specific autoimmune disease.
    Gao J; Killedar S; Cornelius JG; Nguyen C; Cha S; Peck AB
    J Autoimmun; 2006 Mar; 26(2):90-103. PubMed ID: 16413168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of murine lupus with anti-CD4 monoclonal antibodies.
    Wofsy D
    Immunol Ser; 1993; 59():221-36. PubMed ID: 8096400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. L-selectin-specific autoantibodies in murine lupus: possible involvement in abnormal homing and polarization of CD4+ T cell subsets.
    Hattori S; Nishimura H; Tsurui H; Kato M; Endo N; Abe M; Akakura S; Mitsui K; Ishikawa S; Hirose S; Shirai T
    J Immunol; 1998 Aug; 161(3):1231-8. PubMed ID: 9686583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse.
    Werwitzke S; Trick D; Kamino K; Matthias T; Kniesch K; Schlegelberger B; Schmidt RE; Witte T
    Arthritis Rheum; 2005 Nov; 52(11):3629-38. PubMed ID: 16255055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin 6 promotes murine lupus in NZB/NZW F1 mice.
    Finck BK; Chan B; Wofsy D
    J Clin Invest; 1994 Aug; 94(2):585-91. PubMed ID: 8040314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrastructure of myoepithelial cells as a target cell in sialoadenitis of submandibular glands of lupus-prone female NZBxNZWF1 mice.
    Hayashi T; Hayashi H; Fujii T; Adachi C; Hasegawa K
    Virchows Arch; 2008 Aug; 453(2):177-88. PubMed ID: 18563439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-14 alpha, the nexus for primary Sjögren's disease in mice and humans.
    Shen L; Suresh L; Li H; Zhang C; Kumar V; Pankewycz O; Ambrus JL
    Clin Immunol; 2009 Mar; 130(3):304-12. PubMed ID: 19038581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.